Preparing For The Zero Moment Of Truth: Managing Early Awareness In Rare Disease Drug Commercialization
Executive Summary
Awareness of new rare disease drugs develops much earlier than traditional therapies. Biopharma companies need to provide and actively manage information to the many stakeholders interested in new products’ progress and potential.